Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jun 15;83(2):239–245. doi: 10.1054/bjoc.2000.1281

Differential and antagonistic effects of 9- cis -retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro

F Pettersson 1, K W Colston 1, A G Dalgleish 1
PMCID: PMC2363480  PMID: 10901377

Abstract

Retinoids and vitamin D are known to exert important anti-tumour effects in a variety of cell types. In this study the effects of 9- cis -retinoic acid (9cRA) the vitamin D analogues EB1089 and CB1093 on three pancreatic adenocarcinoma cell lines were investigated. All compounds caused inhibition of in vitro growth but the vitamin D analogues were generally the more potent growth inhibitors. They were also more effective on their own than in combination with 9cRA. Growth arrest correlated with an increased proportion of cells in the G0/G1 phase. Apoptosis was induced in the three cell lines by 9cRA, whereas neither EB1089 nor CB1093 had this effect. Furthermore, addition of EB1089 or CB1093 together with 9cRA resulted in significantly reduced apoptosis. Our results show that retinoic acids as well as vitamin D analogues have inhibitory effects on pancreatic tumour cells but different and antagonistic mechanisms seem to be employed. © 2000 Cancer Research Campaign

Keywords: 9- cis -retinoic acid, vitamin D analogues, pancreatic cancer, growth inhibition, apoptosis

Full Text

The Full Text of this article is available as a PDF (340.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bold R. J., Ishizuka J., Townsend C. M., Jr, Thompson J. C. All-trans-retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas. 1996 Mar;12(2):189–195. doi: 10.1097/00006676-199603000-00014. [DOI] [PubMed] [Google Scholar]
  2. Bollag W., Majewski S., Jablonska S. Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia. 1994 Sep;8(9):1453–1457. [PubMed] [Google Scholar]
  3. Chen W. H., Horoszewicz J. S., Leong S. S., Shimano T., Penetrante R., Sanders W. H., Berjian R., Douglass H. O., Martin E. W., Chu T. M. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro. 1982 Jan;18(1):24–34. doi: 10.1007/BF02796382. [DOI] [PubMed] [Google Scholar]
  4. Colston K. W., James S. Y., Ofori-Kuragu E. A., Binderup L., Grant A. G. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer. 1997;76(8):1017–1020. doi: 10.1038/bjc.1997.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Danielsson C., Mathiasen I. S., James S. Y., Nayeri S., Bretting C., Hansen C. M., Colston K. W., Carlberg C. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. J Cell Biochem. 1997 Sep 15;66(4):552–562. doi: 10.1002/(sici)1097-4644(19970915)66:4<552::aid-jcb14>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  6. Danielsson C., Törmä H., Vahlquist A., Carlberg C. Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis. Int J Cancer. 1999 May 5;81(3):467–470. doi: 10.1002/(sici)1097-0215(19990505)81:3<467::aid-ijc22>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  7. Dippold W., Bernhard H., Meyer zum Büschenfelde K. H. Chemotherapy in advanced pancreatic cancer. Int J Pancreatol. 1997 Feb;21(1):39–41. doi: 10.1007/BF02785918. [DOI] [PubMed] [Google Scholar]
  8. Elstner E., Campbell M. J., Munker R., Shintaku P., Binderup L., Heber D., Said J., Koeffler H. P. Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate. 1999 Aug 1;40(3):141–149. doi: 10.1002/(sici)1097-0045(19990801)40:3<141::aid-pros1>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  9. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Evans T. R., Lofts F. J., Mansi J. L., Glees J. P., Dalgleish A. G., Knight M. J. A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer. 1996 May;73(10):1260–1264. doi: 10.1038/bjc.1996.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gansauge S., Gansauge F., Beger H. G. Molecular oncology in pancreatic cancer. J Mol Med (Berl) 1996 Jun;74(6):313–320. doi: 10.1007/BF00207508. [DOI] [PubMed] [Google Scholar]
  12. Gartel A. L., Tyner A. L. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 1999 Feb 1;246(2):280–289. doi: 10.1006/excr.1998.4319. [DOI] [PubMed] [Google Scholar]
  13. Giguere V., Ong E. S., Segui P., Evans R. M. Identification of a receptor for the morphogen retinoic acid. Nature. 1987 Dec 17;330(6149):624–629. doi: 10.1038/330624a0. [DOI] [PubMed] [Google Scholar]
  14. Haussler M. R., Jurutka P. W., Hsieh J. C., Thompson P. D., Selznick S. H., Haussler C. A., Whitfield G. K. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995 Aug;17(2 Suppl):33S–38S. doi: 10.1016/8756-3282(95)00205-r. [DOI] [PubMed] [Google Scholar]
  15. Haussler M. R., Whitfield G. K., Haussler C. A., Hsieh J. C., Thompson P. D., Selznick S. H., Dominguez C. E., Jurutka P. W. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998 Mar;13(3):325–349. doi: 10.1359/jbmr.1998.13.3.325. [DOI] [PubMed] [Google Scholar]
  16. Heyman R. A., Mangelsdorf D. J., Dyck J. A., Stein R. B., Eichele G., Evans R. M., Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992 Jan 24;68(2):397–406. doi: 10.1016/0092-8674(92)90479-v. [DOI] [PubMed] [Google Scholar]
  17. James S. Y., Mackay A. G., Colston K. W. Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol. 1995 Jun;14(3):391–394. doi: 10.1677/jme.0.0140391. [DOI] [PubMed] [Google Scholar]
  18. James S. Y., Mercer E., Brady M., Binderup L., Colston K. W. EB1089, a synthetic analogue of vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro. Br J Pharmacol. 1998 Nov;125(5):953–962. doi: 10.1038/sj.bjp.0702103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. James S. Y., Williams M. A., Newland A. C., Colston K. W. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol. 1999 Jan;32(1):143–154. doi: 10.1016/s0306-3623(98)00098-6. [DOI] [PubMed] [Google Scholar]
  20. Kaiser A., Wolf-Breitinger M., Albers A., Dorbic T., Wittig B., Riecken E. O., Rosewicz S. Retinoic acid receptor gamma1 expression determines retinoid sensitivity in pancreatic carcinoma cells. Gastroenterology. 1998 Oct;115(4):967–977. doi: 10.1016/s0016-5085(98)70269-0. [DOI] [PubMed] [Google Scholar]
  21. Kane K. F., Langman M. J., Williams G. R. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Res. 1996 Feb 1;56(3):623–632. [PubMed] [Google Scholar]
  22. Kawa S., Nikaido T., Aoki Y., Zhai Y., Kumagai T., Furihata K., Fujii S., Kiyosawa K. Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer. 1997;76(7):884–889. doi: 10.1038/bjc.1997.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kawa S., Yoshizawa K., Tokoo M., Imai H., Oguchi H., Kiyosawa K., Homma T., Nikaido T., Furihata K. Inhibitory effect of 220-oxa-1,25-dihydroxyvitamin D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology. 1996 May;110(5):1605–1613. doi: 10.1053/gast.1996.v110.pm8613068. [DOI] [PubMed] [Google Scholar]
  24. Kliewer S. A., Umesono K., Mangelsdorf D. J., Evans R. M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 Jan 30;355(6359):446–449. doi: 10.1038/355446a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Korsmeyer S. J. BCL-2 gene family and the regulation of programmed cell death. Cancer Res. 1999 Apr 1;59(7 Suppl):1693s–1700s. [PubMed] [Google Scholar]
  26. Koshizuka K., Kubota T., Said J., Koike M., Binderup L., Uskokovic M., Koeffler H. P. Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice. Anticancer Res. 1999 Jan-Feb;19(1A):519–524. [PubMed] [Google Scholar]
  27. Levin A. A., Sturzenbecker L. J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 1992 Jan 23;355(6358):359–361. doi: 10.1038/355359a0. [DOI] [PubMed] [Google Scholar]
  28. Liu M., Lee M. H., Cohen M., Bommakanti M., Freedman L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 1996 Jan 15;10(2):142–153. doi: 10.1101/gad.10.2.142. [DOI] [PubMed] [Google Scholar]
  29. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996 Jul;10(9):1031–1039. doi: 10.1096/fasebj.10.9.8801164. [DOI] [PubMed] [Google Scholar]
  30. Louvet C., Djelloul S., Forgue-Lafitte M. E., Mester J., Zimber A., Gespach C. Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha. Br J Cancer. 1996 Aug;74(3):394–399. doi: 10.1038/bjc.1996.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Mathiasen I. S., Colston K. W., Binderup L. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Mol Biol. 1993 Sep;46(3):365–371. doi: 10.1016/0960-0760(93)90226-m. [DOI] [PubMed] [Google Scholar]
  32. Matsumoto T., Sowa Y., Ohtani-Fujita N., Tamaki T., Takenaka T., Kuribayashi K., Sakai T. p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3. Cancer Lett. 1998 Jul 3;129(1):61–68. doi: 10.1016/s0304-3835(98)00080-9. [DOI] [PubMed] [Google Scholar]
  33. Nagy L., Thomazy V. A., Heyman R. A., Davies P. J. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ. 1998 Jan;5(1):11–19. doi: 10.1038/sj.cdd.4400337. [DOI] [PubMed] [Google Scholar]
  34. Okabe T., Yamaguchi N., Ohsawa N. Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. Cancer. 1983 Feb 15;51(4):662–668. doi: 10.1002/1097-0142(19830215)51:4<662::aid-cncr2820510419>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  35. Petkovich M., Brand N. J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 1987 Dec 3;330(6147):444–450. doi: 10.1038/330444a0. [DOI] [PubMed] [Google Scholar]
  36. Philpott N. J., Turner A. J., Scopes J., Westby M., Marsh J. C., Gordon-Smith E. C., Dalgleish A. G., Gibson F. M. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood. 1996 Mar 15;87(6):2244–2251. [PubMed] [Google Scholar]
  37. Rosewicz S., Stier U., Brembeck F., Kaiser A., Papadimitriou C. A., Berdel W. E., Wiedenmann B., Riecken E. O. Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology. 1995 Nov;109(5):1646–1660. doi: 10.1016/0016-5085(95)90655-x. [DOI] [PubMed] [Google Scholar]
  38. Rosewicz S., Wiedenmann B. Pancreatic carcinoma. Lancet. 1997 Feb 15;349(9050):485–489. doi: 10.1016/s0140-6736(96)05523-7. [DOI] [PubMed] [Google Scholar]
  39. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., Boyd M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990 Jul 4;82(13):1107–1112. doi: 10.1093/jnci/82.13.1107. [DOI] [PubMed] [Google Scholar]
  40. Tan M. H., Nowak N. J., Loor R., Ochi H., Sandberg A. A., Lopez C., Pickren J. W., Berjian R., Douglass H. O., Jr, Chu T. M. Characterization of a new primary human pancreatic tumor line. Cancer Invest. 1986;4(1):15–23. doi: 10.3109/07357908609039823. [DOI] [PubMed] [Google Scholar]
  41. Wang Q. M., Jones J. B., Studzinski G. P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996 Jan 15;56(2):264–267. [PubMed] [Google Scholar]
  42. Wang X., Studzinski G. P. Antiapoptotic action of 1,25-dihydroxyvitamin D3 is associated with increased mitochondrial MCL-1 and RAF-1 proteins and reduced release of cytochrome c. Exp Cell Res. 1997 Aug 25;235(1):210–217. doi: 10.1006/excr.1997.3667. [DOI] [PubMed] [Google Scholar]
  43. Zugmaier G., Jäger R., Grage B., Gottardis M. M., Havemann K., Knabbe C. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer. 1996 Jun;73(11):1341–1346. doi: 10.1038/bjc.1996.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. el-Deriny S. E., O'Brien M. J., Christensen T. G., Kupchik H. Z. Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. Pancreas. 1987;2(1):25–33. doi: 10.1097/00006676-198701000-00004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES